Ikrish Healthcare Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.00 Cr
as on 16-11-2024
- Company Age 16 Year, 20 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 23.80 Cr
as on 16-11-2024
- Revenue 272.39%
(FY 2023)
- Profit -59.83%
(FY 2023)
- Ebitda -32.66%
(FY 2023)
- Net Worth -312.47%
(FY 2023)
- Total Assets 19.53%
(FY 2023)
About Ikrish Healthcare
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹23.80 Cr.
Neelam Sharma and Mahendra Singh serve as directors at the Company.
- CIN/LLPIN
U85100DL2008PTC185876
- Company No.
185876
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ikrish Healthcare Private Limited offer?
Ikrish Healthcare Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Organic Soap, Cosmetics, Hair & Beauty Products, Body Cream, Face Wash.
Who are the key members and board of directors at Ikrish Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neelam Sharma  | Director | 01-Jul-2021 | Current |
| Mahendra Singh | Director | 22-Feb-2022 | Current |
Financial Performance of Ikrish Healthcare.
Ikrish Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 272.39% increase. The company also saw a substantial fall in profitability, with a 59.83% decrease in profit. The company's net worth observed a substantial decline by a decrease of 312.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ikrish Healthcare?
In 2023, Ikrish Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tamilnad Mercantile Bank Limited Creation Date: 04 Nov 2019 | ₹20.10 Cr | Open |
Tamilnad Mercantile Bank Limited Creation Date: 04 Nov 2019 | ₹3.70 Cr | Open |
How Many Employees Work at Ikrish Healthcare?
Ikrish Healthcare has a workforce of 41 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ikrish Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ikrish Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
